Summary
- Current Price
- As of today, SOLV price is $88.61, up +0.91% on
- Current Price All-Time High
- SOLV price is currently -1.54% below its historical high of $90.00 set on
- Market Cap
- SOLV current market cap is $15B, up +19.41% over the past 365 days
- PE Ratio
- SOLV current PE ratio is 10.83
- Revenue
- SOLV current annual revenue is $8.33B, up +0.86% year-over-year
- Next Earnings
- The next earnings release for SOLV is on
Profile
| Metric | Value |
|---|---|
| Full Name | Solventum Corporation |
| Ticker | NYSE: SOLV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | solventum.com |
| Employees | 22,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $88.61 | |
| Price, 1D Change | +0.91% | |
| Market Cap | $15B | |
| - | ||
| PE Ratio | 10.83 | |
| Beta | 0.63 | |
| Revenue | $8.33B | |
| Revenue, 1Y Change | +0.86% | |
| EPS | $8.88 | |
| EPS, 1Y Change | +221.88% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | SOLV.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $8.88 | |
| EPS Estimate | $7.18 | N/A |
| EPS Est. Change | -19.07% | N/A |
| Revenue | $8.33B | |
| Revenue Estimate | $8.23B | N/A |
| Revenue Est. Change | -1.17% | N/A |
| Current Price | $88.61 | |
| Price Target | $95.00 | - |
| Price Tgt. Change | +7.21% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.57 | $2.76 | -58.00% | |
| $6.02 | $8.88 | +47.36% | |
| $7.18 | N/A | -19.07% | |
| $7.22 | N/A | -18.65% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.23B | $8.25B | +0.28% | |
| $8.27B | $8.33B | +0.63% | |
| $8.23B | N/A | -1.17% | |
| $8.51B | N/A | +2.26% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +21.63% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +19.41% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +0.86% | |
| Revenue, 3Y | +2.40% | |
| EPS, 1Y | +221.88% | |
| EPS, 3Y | +14.15% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $88.61 | |
| SMA 200 | $76.24 | |
| SMA 50 | $80.77 | |
| EMA 200 | $76.36 | |
| EMA 50 | $81.64 | |
| MACD | $2.16 | |
| Beta | 0.63 | |
| ATR | $2.74 | |
| 14-Day RSI | 62.18 | |
| 10-Day Volatility | 36.30% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $8.33B | |
| EPS | $8.88 | |
| Gross Profit | $0.00 | |
| Gross Margin | 53.59% | |
| Operating Income | $719.00M | |
| Operating Margin | 8.64% | |
| Net Income | $1.56B | |
| Net Margin | 18.69% | |
| EBITDA | $1.21B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 1.04 | |
| 1.23 | ||
| 0.89 | ||
| - | ||
| 6 | ||
| 1.80 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 10.83 | |
| 1.82 | ||
| 3.14 | ||
| 16.86 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $5.05B | |
| $878.00M | ||
| $14.29B | ||
| $3.86B | ||
| $9.25B | ||
| $3.14B | ||
| Total Debt | $5.25B | |
| $70.00M | ||
| $687.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $6.77B | ||
| $3.74B | ||
| $3.86B | ||
| $3.08B | ||
| $489.00M | ||
| $0.00 | ||
| $157.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $369.00M | ||
| $2.80B | ||
| -$3.06B | ||
| Capex | $379.00M | |
| -$10.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| UBS | → | |
| Stifel | → | |
| Piper Sandler | → | |
| Keybanc | → | |
| BTIG | → | |
| UBS | → | |
| BMO Capital | ||
| Wedbush | ||
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with SOLV
FAQ
- What is the ticker symbol for Solventum Corporation?
- The ticker symbol for Solventum Corporation is NYSE:SOLV
- Does Solventum Corporation pay dividends?
- No, Solventum Corporation does not pay dividends
- What sector is Solventum Corporation in?
- Solventum Corporation is in the Healthcare sector
- What industry is Solventum Corporation in?
- Solventum Corporation is in the Medical Instruments & Supplies industry
- What country is Solventum Corporation based in?
- Solventum Corporation is headquartered in United States
- When did Solventum Corporation go public?
- Solventum Corporation initial public offering (IPO) was on April 1, 2024
- Is Solventum Corporation in the S&P 500?
- Yes, Solventum Corporation is included in the S&P 500 index
- Is Solventum Corporation in the NASDAQ 100?
- No, Solventum Corporation is not included in the NASDAQ 100 index
- Is Solventum Corporation in the Dow Jones?
- No, Solventum Corporation is not included in the Dow Jones index
- When was Solventum Corporation last earnings report?
- Solventum Corporation's most recent earnings report was on August 5, 2026
- When does Solventum Corporation report earnings?
- The next expected earnings date for Solventum Corporation is November 5, 2026
Data Sources & References
- SOLV Official Website www.solventum.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- SOLV Profile on Yahoo Finance finance.yahoo.com/quote/SOLV
- SOLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/solv